ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,818Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 232

$946K Total Retail Price of All Prescriptions

Rank: 23 out of 232

567 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 567 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 567 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 14,737 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 719 682 1 1
AMLODIPINE BESYLATE 546 526 2 2
LISINOPRIL 514 495 3 6
OMEPRAZOLE 429 418 4 4
CITALOPRAM HBR 421 388 5 24
LEVOTHYROXINE SODIUM 410 399 6 3
ATORVASTATIN CALCIUM 409 403 7 14
ZOLPIDEM TARTRATE 398 373 8 19
NAMENDA 371 367 9 18
LOSARTAN POTASSIUM 346 346 10 15
TRAMADOL HCL 294 281 11 33
WARFARIN SODIUM 286 233 12 8
METFORMIN HCL 286 271 12 9
TRAMADOL HCL-ACETAMINOPHEN 252 245 14 203
DONEPEZIL HCL 249 249 15 13
TRAZODONE HCL 245 243 16 38
HYDROCHLOROTHIAZIDE 243 235 17 16
HYDROCODONE-ACETAMINOPHEN 237 198 S3 18 5
SERTRALINE HCL 227 213 19 35
METOPROLOL TARTRATE 214 173 20 10
ESCITALOPRAM OXALATE 211 201 21 54
ALENDRONATE SODIUM 209 208 22 17
FUROSEMIDE 207 186 23 7
POTASSIUM CHLORIDE 193 190 24 20
ATENOLOL 177 168 25 11
METOPROLOL SUCCINATE 174 171 26 23
HYDRALAZINE HCL 162 162 27 62
CARBIDOPA-LEVODOPA 160 156 28 59
CARVEDILOL 152 143 29 21
BUPROPION XL 144 132 30 237
LOSARTAN-HYDROCHLOROTHIAZIDE 143 143 31 88
PANTOPRAZOLE SODIUM 136 129 32 26
ADVAIR DISKUS 134 107 33 44
GABAPENTIN 126 81 34 12
CYMBALTA 120 97 35 57
TAMSULOSIN HCL 120 117 35 22
PREDNISONE 118 105 37 49
CIPROFLOXACIN HCL 109 104 38 68
SPIRIVA 109 100 38 84
QUETIAPINE FUMARATE 103 103 40 41
DIGOXIN 101 94 41 37
BENICAR HCT 100 100 42 168
GLIPIZIDE 100 98 42 29
AZITHROMYCIN 99 97 44 51
ZETIA 99 98 44 136
ABILIFY 95 67 46 146
SPIRONOLACTONE 87 79 47 77
BENICAR 87 87 47 160
LEVETIRACETAM 85 66 49 72
LEXAPRO 83 80 50 170
CLOPIDOGREL 83 83 50 34
DIOVAN 82 82 52 27
CELEBREX 79 78 53 63
BUMETANIDE 77 76 54 291
ISOSORBIDE MONONITRATE ER 77 74 54 52
LYRICA 74 74 56 134
BYSTOLIC 69 69 57 175
LIDODERM 63 63 58 48
CRESTOR 63 63 58 56
PLAVIX 63 63 58 50
SEROQUEL 62 61 61 105
VENLAFAXINE HCL ER 62 54 61 167
ALLOPURINOL 61 58 63 39
MEGESTROL ACETATE 60 59 R 64 102
CLOTRIMAZOLE-BETAMETHASONE 58 50 65 195
PRANDIN 58 58 65 220
POLYETHYLENE GLYCOL 3350 57 51 67 92
PROAIR HFA 52 43 68 79
LEVOFLOXACIN 52 45 68 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 28, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.